Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis.

Naon, H; Hack, S; Shelton, M T; Gotthoffer, R C; Gozal, D

Naon, H; Hack, S; Shelton, M T; Gotthoffer, R C; Gozal, D.

Affiliation

Naon H; Division of Gastroenterology and Nutrition, Childrens Hospital Los Angeles 90027.

Chest ; 103(6): 1819-25, 1993 Jun.

Article in En | MEDLINE | ID: mdl-8404106

Subject(s)

Anti-Bacterial Agents/therapeutic use; Cystic Fibrosis/metabolism; Energy Metabolism; Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis/complications; Cystic Fibrosis/physiopathology; Diet; Energy Intake; Female; Humans; Male; Respiratory Mechanics; Respiratory Tract Infections/complications; Respiratory Tract Infections/drug therapy; Weight Loss

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cystic Fibrosis / Energy Metabolism / Anti-Bacterial Agents Type of study: Health_economic_evaluation Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Chest Year: 1993 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links